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Abstract
 Around a quarter of people post stroke will experienceBackground:
aphasia, a language disability. Having aphasia places someone at risk of
becoming depressed and isolated. There is limited evidence for effective
interventions to enhance psychological well-being for this client group. A
potential intervention is Solution Focused Brief Therapy (SFBT), which
supports a person to build meaningful, achievable change through focusing
on a person’s skills and resources rather than their deficits. The SOFIA Trial
aims to explore the acceptability of SFBT to people with varying
presentations of aphasia, including severe aphasia, and to assess the
feasibility of conducting a future definitive trial investigating clinical and cost
effectiveness.
 The trial is a single-blind, randomised, wait-list controlledMethods:
feasibility trial with nested qualitative research and pilot economic
evaluation comparing SFBT plus usual care to usual care alone. The study
will recruit 32 participants with aphasia who are ≥6 months post stroke. All
participants will be assessed on psychosocial outcome measures at
baseline, three, and six months post randomisation by assessors blinded to
treatment allocation. Participants will be randomly assigned to intervention
group (start intervention immediately post randomisation) or wait-list group
(start intervention six months post randomisation). Wait-list group will
additionally be assessed nine months post randomisation. The intervention
consists of up to six SFBT sessions delivered over three months by speech
and language therapists. Participants and therapists will also take part in
in-depth interviews exploring their experiences of the study. The pilot
economic evaluation will use the EQ-5D-5L measure and an adapted Client
Service Receipt Inventory. People with aphasia have been involved in
designing and monitoring the trial.
 Given the high levels of depression and isolation, there is aDiscussion:
need to investigate effective interventions that enhance the psychological
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need to investigate effective interventions that enhance the psychological
wellbeing of people with aphasia.
 ClinicalTrials.gov   10/08/2017.Trial registration: NCT03245060
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Introduction
Aphasia occurs following brain damage and can affect a person’s 
ability to talk, understand, read or write. There are 110,000 
strokes each year in England1. Around 45% of people will 
experience aphasia immediately post stroke; by three months, the 
aphasia persists for 24% of the stroke population2. It is estimated 
that for 15% of people post stroke the aphasia will be a life-long 
condition3. The impact of losing language skills on a person’s 
identity and well-being can be considerable. Those with apha-
sia are disproportionately likely to lose contact with friends4,5, 
and have weaker social networks6 than those without aphasia. 
Further, rates of depression post stroke are high for people with 
aphasia with one study finding that 70% of people with aphasia 
at 3 months and 62% at 12 months post stroke fulfilled the 
DSM-III-R criteria for depression7. Expressive communication 
impairment has also been found to be a significant predictor of 
depression at one and six months post stroke8.
There has been increasing recognition of the need to consider 
the psychological consequences of long-term health conditions9. 
Stroke service guidelines in the UK state that ‘psychological 
care for this group [people post stroke] is as essential as physi-
cal rehabilitation’10. Yet the UK Stroke Association reported 
that two thirds of stroke survivors felt their emotional needs 
were not as well addressed as their physical needs11. Services 
addressing longer-term psychological well-being post stroke 
have been identified as particularly weak1. A study exploring the 
views of UK speech and language therapists found that people 
with aphasia were observed to be at risk of not receiving appro-
priate psychological support. In part this was due to mental health 
professionals finding it difficult to deliver care due to the 
communication difficulties. Conversely although speech and 
language therapists were able to facilitate communication they 
often lacked the necessary support or training to feel confident 
addressing psychological needs12,13. There was particular 
concern about people with more severe aphasia accessing mental 
health support13.
Most studies exploring effective psychological interventions post 
stroke exclude people with aphasia14, and a systematic review 
of interventions to prevent and treat depression in post-stroke 
aphasia found only limited evidence15. The only randomised 
controlled trial reporting significant benefit when treating low 
mood in people with aphasia was the Communication and Low 
Mood (CALM) study16 where behavioural activation therapy 
was delivered by assistant psychologists.
While severe or persistent mood disorders require specialist 
input from mental health professionals17, there has been increas-
ing recognition that psychological care is the concern of the 
whole healthcare team18. UK health service guidelines suggest 
that mild/moderate symptoms of depression, commonly experi-
enced post stroke, may be addressed by non-psychology stroke 
specialist staff with support from clinical psychologists17. In 
two surveys of aphasia-specialist speech and language thera-
pists the vast majority (98% in Australia19; 93% in UK12) 
agreed that addressing the psychological needs of their clients 
was a part of their role. However, only a minority (31% in 
Australia19; 42% in UK12) reported that they felt confident to do 
so. There is currently a lack of research evaluating an intervention 
for mild/moderate depression which may enhance psychological 
well-being delivered by speech and language therapists with 
appropriate support.
One potential psychological intervention is Solution Focused 
Brief Therapy (SFBT) which is a client-centred resource-based 
therapy that aims to enable people to build change in their 
everyday lives20,21. It explores a person’s hopes, how they would 
like their life to be, and builds on what is already working. 
The client is considered expert in their own life and takes on 
expert status within the therapeutic relationship. The assump-
tion is that the client will have the resources and skills they need 
to resolve the problem; rather than offer advice, the therapist’s 
role is to ask questions and listen in such a way that the client 
notices their own strengths and can formulate their own way of 
moving forwards. Acknowledgement of distress, including recog-
nition of the impact of the stroke and aphasia, is also part of the 
therapy process in this study. The strongest evidence for the effec-
tiveness of SFBT is in treating depression in neurotypical adults22. 
Further, there is a growing evidence base for its effectiveness in 
managing chronic ill-health, for example, managing fatigue in 
Crohn’s disease23 and coping with HIV/AIDS24.
A proof-of-concept study exploring SFBT with five people 
who had mild to moderate post-stroke aphasia reported encour-
aging trends in terms of improved mood and communicative 
participation and a main theme from the qualitative interviews 
was increased confidence25. The current study extends this pre-
liminary work in a feasibility trial with the aim of informing the 
design and feasibility of a full-scale definitive trial. Following 
consultation work with people with aphasia the project focuses 
on living with stroke and aphasia in the longer term. We are 
therefore recruiting participants at least six months post stroke.
      Amendments from Version 1
Differences between this version and previous version:
1.   Reference 22 is a review articles which concludes that the 
strongest evidence for the effectiveness of Solution Focused Brief 
Therapy is in treating depression. We have clarified that this refers 
to studies treating neurotypical adults.
2.   Recruitment window dates correction: recruitment finished on 
5th November 2018. Data collection is still ongoing.
See referee reports
REVISED
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Aims
The aim of the study is to assess the feasibility of conducting a 
future definitive trial investigating the clinical and cost effective-
ness of Solution Focused Brief Therapy for people living with 
chronic post-stroke aphasia. Primary objectives of the trial are 
to evaluate the acceptability of the intervention to participants 
with varying severity and presentation of aphasia as well to the 
trial clinicians; the feasibility of recruitment and retention; 
the acceptability of research procedures; and the feasibility of 
delivering the intervention by speech and language thera-
pists. Secondary objectives are to evaluate the appropriateness 
of outcome measures; estimate a sample size for the definitive 
trial; and assess processes for evaluating treatment fidelity and 
documenting usual care.
Methods
Design
This study is a single-blind, randomised, wait-list control-
led feasibility trial comparing Solution Focused Brief Therapy 
plus usual care to usual care alone for people living with 
chronic post-stroke aphasia. All participants complete baseline 
assessment and are then randomised either to receive the inter-
vention immediately or after a delay of six months. Both groups 
complete assessments at three months and six months post ran-
domisation; the wait-list group are also assessed nine months post 
randomisation. All participants are also invited to take part in in-
depth interviews six months post randomisation in order to explore 
their experiences of taking part in the study; the wait-list group 
take part in an additional in-depth interview nine months post 
randomisation. Figure 1 illustrates the flow of participants 
throughout the study.
The Consolidated Standards of Reporting Trials (CONSORT) 
2010 extension statement to randomised pilot and feasibility 
trials26 informed the study design. The Standard Protocol Items: 
Recommendations for Interventional Trials (SPIRIT) 2013 
statement27 guided the writing of the study protocol. The Tem-
plate for Intervention Description and Replication (TIDieR)28 
informed the description of the intervention (see Table 1).
Ethical approval
Ethical approval to conduct the study was granted by the NHS 
Health Research Authority Brighton and Sussex Research Ethics 
Committee (17/LO/1255). Local NHS Research and Devel-
opment approvals have also been gained from participating 
sites. The trial sponsor is City, University of London (Staff/17-
18/04), and the study is funded by the Stroke Association 
(TSA Postdoc 2016/01).
Participants
Setting. Participants will be identified through two National 
Health Service (NHS) community speech and language therapy 
services, in East and West London, United Kingdom. We will also 
recruit via non-NHS community routes, for example, through 
working with the voluntary sector. All visits will be conducted 
in the venue of the participant’s choice, anticipated to be either 
the participant’s home or the university clinic.
Participants: inclusion and exclusion criteria. Participants 
will have a diagnosis of ischaemic or haemorrhagic stroke, be 
at least six months post stroke, 18 years old or over, and pre-
senting with aphasia. Presence of aphasia will be determined 
by the clinical judgement of a speech and language therapist. 
Participants will be excluded if they: have other diagnoses 
affecting cognition such as dementia or advanced Parkinson’s 
Disease; have severe uncorrected visual or hearing problems; 
have severe or potentially terminal co-morbidity; are currently 
receiving a psychological or psychiatric intervention from a 
mental health professional; were non-fluent English speakers 
prior to the stroke (based on self or family report); or do not have 
mental capacity to consent to take part. We are including people 
with any severity of aphasia, providing they have capacity. Use 
of anti-depressants or rehabilitation therapy will be recorded but 
will not be a reason for exclusion.
Recruitment and consent processes
The clinical care teams at the two participating NHS sites will 
screen people on their caseloads against the eligibility cri-
teria before discussing the study with potential participants 
during a routine therapy or review appointment using a one-page 
summary information sheet (Extended data29). Where a person 
is potentially interested in taking part the clinician will ask per-
mission to pass their contact details to the chief investigator (SN) 
who will then arrange to meet them to discuss the project further.
Methods of community recruitment are diverse to allow com-
parison of different strategies. They include: visiting stroke and 
aphasia groups; accepting self-referrals (e.g. where a poten-
tial participant has learnt about the project from the funder’s 
website, twitter, project blog or word of mouth); distributing 
information about the project to third sector organisations; 
contacting people known to the University who have given 
permission for their details to be shared for this purpose. For 
those participants recruited via the community we will check 
they meet the eligibility criteria through asking a series of 
questions and relying on self-report.
Written informed consent will be obtained from all partici-
pants who are able to give it. For participants who are physically 
unable to sign the form an independent witness will sign on 
their behalf. All information sheets and consent forms have 
been developed using standard aphasia-accessible principles 
(e.g. presenting one idea at a time, using short simple sentences, 
presenting key ideas with a suitable pictorial image). They 
have been based on templates created by the National Institute 
for Health Research30 and informed by observations made by 
the SOFIA Aphasia Advisory Group. The chief investigator 
(SN), who is an experienced speech and language therapist, will 
meet with all potential participants to go through the participant 
information sheet (Extended data29) and facilitate the person 
with aphasia discussing and asking questions about the project. 
Potential participants will receive the participant information 
sheet at least 24 hours in advance of this meeting. A person’s 
capacity to give informed consent will be made by SN, both 
informally and through asking three simple yes/no or forced 
alternative questions to confirm whether they have understood 
key aspects of the study.
Participants may withdraw consent to participate in the study 
at any time and without giving a reason although we will record 
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the reason if known. They may also elect to discontinue with the 
intervention but continue in the trial in which case we will seek 
permission to collect outcome data and carry out in-depth 
interviews with them.
Randomisation
The King’s Clinical Trials Unit will provide the randomisation 
service. After the baseline assessment visit has been completed 
the chief investigator will access the allocation for each 
participant by logging into the remote, secure internet-based 
randomisation system. Participants will be randomised in equal 
proportions to either the intervention group or the wait-list group. 
Randomisation allocation will use minimisation with a random 
component to avoid predictability of allocation. Minimisation 
will be based on two factors: site (two NHS trusts, community) 
and aphasia severity. Aphasia severity will be determined accord-
ing to participants’ scores on the Frenchay Aphasia Screening 
Test31: if a participant scores <7 on either the receptive or 
expressive domains during baseline assessment they will be 
classified as having severe aphasia.
Blinding
Participants, trial clinicians, the qualitative researcher, and the 
chief investigator will be aware of group allocation. However, the 
Figure 1. SOFIA Trial Flowchart.
Page 5 of 18
AMRC Open Research 2019, 1:11 Last updated: 28 AUG 2019
Ta
bl
e 
1.
 
SO
FI
A 
Tr
ia
l: 
Te
m
pl
at
e 
fo
r 
In
te
rv
en
tio
n 
De
sc
rip
tio
n 
an
d 
Re
pl
ic
at
io
n 
(T
ID
ieR
) c
he
ck
lis
t.
Ite
m
D
es
cr
ip
tio
n
1:
 
N
am
e
SO
lu
tio
n 
Fo
cu
se
d 
B
rie
f T
he
ra
py
 In
 p
os
t-s
tro
ke
 A
ph
as
ia
 (S
O
FI
A
 T
ria
l)
2:
 
R
at
io
na
le
, 
th
eo
ry
 o
r g
oa
l 
o
f t
he
 in
te
rv
en
tio
n
Th
e 
ai
m
 o
f t
he
 in
te
rv
en
tio
n 
is
 to
 e
nh
an
ce
 p
sy
ch
ol
og
ic
al
 w
el
l-b
ei
ng
. S
ol
ut
io
n 
Fo
cu
se
d 
B
rie
f T
he
ra
py
 (S
FB
T)
 h
yp
ot
he
si
se
s 
th
at
 in
 e
na
bl
in
g 
a 
cl
ie
nt
 to
 
de
sc
rib
e 
th
ei
r p
re
fe
rr
ed
 fu
tu
re
, a
s 
w
el
l a
s 
no
tic
e 
th
ei
r c
om
pe
te
nc
ie
s,
 s
ki
lls
, a
nd
 in
st
an
ce
s 
of
 s
uc
ce
ss
, t
he
 c
lie
nt
 c
an
 b
e 
su
pp
or
te
d 
in
 b
ui
ld
in
g 
po
si
tiv
e 
ch
an
ge
20
,3
2 .
3:
 
M
at
er
ia
ls
 fo
r 
tr
ai
ni
ng
 a
nd
 
de
liv
er
y
A
 th
er
ap
y 
m
an
ua
l h
as
 b
ee
n 
de
ve
lo
pe
d 
to
 g
ui
de
 th
e 
tra
in
in
g 
an
d 
su
pe
rv
is
io
n 
of
 tr
ia
l c
lin
ic
ia
ns
, a
s 
w
el
l a
s 
th
e 
de
liv
er
y 
of
 th
e 
in
te
rv
en
tio
n.
 T
he
 m
an
ua
l 
de
sc
rib
es
 th
e 
ba
si
c 
te
ne
ts
 o
f S
ol
ut
io
n 
Fo
cu
se
d 
B
rie
f T
he
ra
py
, d
ra
w
in
g 
on
 e
st
ab
lis
he
d 
de
sc
rip
tio
ns
 o
f t
he
 a
pp
ro
ac
h,
 fo
r e
xa
m
pl
e,
 p
ro
vi
de
d 
by
 th
e 
U
ni
te
d 
K
in
gd
om
 A
ss
oc
ia
tio
n 
fo
r S
ol
ut
io
n 
Fo
cu
se
d 
Pr
ac
tic
e.
 It
 fo
llo
w
s 
th
e 
m
od
el
 o
f S
ol
ut
io
n 
Fo
cu
se
d 
B
rie
f T
he
ra
py
 d
ev
el
op
ed
 b
y 
Ev
an
s,
 Iv
es
on
 a
nd
 R
at
ne
r2
0 . 
Tr
ia
l c
lin
ic
ia
ns
 w
ill
 re
ce
iv
e 
a 
co
py
 o
f t
he
 m
an
ua
l a
s 
w
el
l a
s 
ad
di
tio
na
l r
es
ou
rc
es
 s
uc
h 
as
 P
ow
er
Po
in
t s
lid
es
 a
nd
 c
he
ck
lis
ts
. 
N
o 
sp
ec
ifi
c 
m
at
er
ia
ls
 a
re
 re
qu
ire
d 
fo
r t
he
 d
el
iv
er
y 
of
 th
e 
in
te
rv
en
tio
n.
 H
ow
ev
er
, t
o 
en
su
re
 th
at
 th
e 
in
te
rv
en
tio
n 
is
 a
cc
es
si
bl
e 
to
 p
eo
pl
e 
w
ith
 m
or
e 
se
ve
re
 
ap
ha
si
a,
 th
er
ap
is
ts
 w
ill
 u
se
 p
ic
to
ria
l r
es
ou
rc
es
 in
cl
ud
in
g 
th
os
e 
de
ve
lo
pe
d 
by
 T
al
ki
ng
 M
at
s 
©
. I
n 
ad
di
tio
n,
 th
er
ap
is
ts
 w
ill
 u
se
 p
ap
er
 a
nd
 p
en
 to
 fa
ci
lit
at
e 
to
ta
l c
om
m
un
ic
at
io
n,
 fo
r e
xa
m
pl
e,
 d
ra
w
in
g 
pi
ct
ur
es
, d
ia
gr
am
s 
or
 s
ca
le
s,
 o
r w
rit
in
g 
do
w
n 
ke
y 
w
or
ds
. T
he
y 
w
ill
 a
ls
o 
us
e 
ob
je
ct
s 
in
 th
e 
en
vi
ro
nm
en
t a
nd
 b
e 
re
sp
on
si
ve
 to
 m
od
es
 o
f c
om
m
un
ic
at
io
n 
an
d 
m
at
er
ia
ls
 p
re
fe
rr
ed
 b
y 
th
e 
pa
rt
ic
ip
an
t e
.g
. u
se
 o
f p
ap
er
 d
ia
ry
 o
r i
Pa
d.
 
4:
 
Th
e 
In
te
rv
en
tio
n:
 
Pr
o
ce
du
re
s,
 
ac
tiv
iti
es
, 
pr
o
ce
ss
es
SF
B
T 
is
 a
 ta
lk
-b
as
ed
 p
sy
ch
ol
og
ic
al
 in
te
rv
en
tio
n.
 It
 e
xp
lo
re
s 
ho
w
 a
 p
er
so
n 
w
ou
ld
 li
ke
 th
ei
r l
ife
 to
 b
e 
an
d 
th
ei
r h
op
es
 fo
r t
he
 fu
tu
re
. I
t a
ls
o 
se
ek
s 
to
 e
na
bl
e 
pe
op
le
 to
 n
ot
ic
e 
th
ei
r o
w
n 
re
so
ur
ce
s,
 re
si
lie
nc
e,
 a
nd
 w
ha
t i
s 
al
re
ad
y 
w
or
ki
ng
. A
s 
th
e 
pa
rt
ic
ip
an
t i
s 
co
ns
id
er
ed
 e
xp
er
t i
n 
th
ei
r o
w
n 
liv
es
, t
he
 th
er
ap
is
t 
re
fra
in
s 
fro
m
 o
ffe
rin
g 
ad
vi
ce
, s
ol
ut
io
ns
 o
r s
tra
te
gi
es
, a
nd
 in
st
ea
d 
se
ek
s 
to
 fa
ci
lit
at
e 
th
e 
cl
ie
nt
 in
 fi
nd
in
g 
th
ei
r o
w
n 
w
ay
 fo
rw
ar
d.
 
K
ey
 a
ss
um
pt
io
ns
: 
It 
is
 a
nt
ic
ip
at
ed
 th
at
 th
e 
th
er
ap
is
t w
ill
 h
ol
d 
in
 m
in
d 
ce
rt
ai
n 
ke
y 
as
su
m
pt
io
ns
 th
ro
ug
ho
ut
 th
e 
th
er
ap
y 
pr
oc
es
s.
 T
he
se
 in
cl
ud
e:
 th
e 
pa
rt
ic
ip
an
t i
s 
ex
pe
rt
 
in
 th
ei
r o
w
n 
liv
es
 th
us
 w
ill
 d
ire
ct
 th
e 
sh
ap
e 
of
 th
e 
th
er
ap
y 
se
ss
io
ns
; t
ha
t a
ll 
pa
rt
ic
ip
an
ts
 h
av
e 
re
so
ur
ce
s,
 ta
le
nt
s,
 c
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 c
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 c
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 p
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t f
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 d
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 p
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; p
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er
ap
is
ts
 w
ith
 e
xp
er
ie
nc
e 
of
 w
or
ki
ng
 w
ith
 p
eo
pl
e 
w
ith
 a
ph
as
ia
. T
he
 tr
ia
l c
lin
ic
ia
ns
 re
ce
iv
e 
fo
ur
 
da
ys
 ‘f
ou
nd
at
io
n 
tra
in
in
g’
 in
 th
e 
co
re
 p
rin
ci
pl
es
 a
nd
 p
ra
ct
ic
es
 o
f S
ol
ut
io
n 
Fo
cu
se
d 
B
rie
f T
he
ra
py
 a
t t
he
 B
rie
f C
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ce
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t C
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r p
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 d
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 m
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 d
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l c
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 c
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 d
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Page 7 of 18
AMRC Open Research 2019, 1:11 Last updated: 28 AUG 2019
research assistants who conduct the psychosocial outcome assess-
ments will be blinded to group allocation. To reduce the likelihood 
of research assistants becoming unblinded we will request that 
participants do not reveal their group allocation during assessment 
visits (both prior to the visit and at the start of the visit); visits 
will be organised by the chief investigator; and research assist-
ants will have no access to participant files or details that could 
potentially unblind them. If a researcher becomes unblinded 
this will be reported and any subsequent visits will be carried 
out by a different research assistant. Near misses will also be 
reported. The final visit for the wait-list group (nine months post 
randomisation) will be conducted by a research assistant blinded 
to both group allocation and time point. A log will be kept 
of all instances of unblinding and near misses, as well as the 
reason for the unblinding.
Intervention
The intervention, therapist training and approach to measuring 
intervention fidelity are described using the TIDieR checklist (see 
Table 1)28. The wait-list group will receive the same interven-
tion six months post randomisation. Both groups will addition-
ally receive all usual care, including health care, social care and 
voluntary services. Usual care will be recorded for both groups 
at six months post randomisation. The choice of study design 
and comparator was influenced by the SOFIA Aphasia Advisory 
Group who considered acceptability to potential participants.
Outcomes
Trial data will be reported and presented according to the 
CONSORT 2010 statement: extension to randomised pilot and 
feasibility trials26. A CONSORT diagram of recruitment and 
participation will be used as shown in Figure 2. We will report 
participant characteristics, as well as proportion of participants 
receiving rehabilitation therapy or anti-depressants, overall 
and by trial arm.
As a feasibility study the main endpoints relate to feasibility 
objectives. We outline four primary and four secondary end-
points. We also state pre-specified criteria for three of the four 
primary endpoints to guide the decision as to whether to proceed 
to a future definitive trial: the extent to which these thresholds 
have been met will be considered in conjunction with qualita-
tive evidence. The pre-specified criteria are based on published 
trials investigating complex behavioural interventions with 
people with aphasia16,33 or stroke34,35: reported recruitment, reten-
tion and adherence rates have informed what we consider to 
be realistic progression criteria. We will consider data from 
all time points including nine months post randomisation as 
appropriate. Clinical and economic evaluation outcome measures 
are listed in Table 2.
Primary endpoints 
[1] Acceptability of the intervention to participants and trial 
clinicians: evaluation based on rates of adherence to interven-
tion where participants considered to have adhered if they elect 
to receive at least two therapy sessions; in-depth interviews with 
participants and trial clinicians; qualitative evaluation of trial 
clinicians’ therapy records e.g. clinician comments on accept-
ability; scores on the Session Rating Scale36 assessing therapeutic 
alliance. Pre-specified criterion 1: proportion of participants 
who adhere (receive at least two therapy sessions) at least 80%.
[2] Feasibility of recruitment and retention to the trial: evalu-
ation based on proportion who give permission for their clinical 
care team to pass on contact details to the central research team; 
the proportion who consent; the rate of participants randomised 
each month; attrition rates (overall, by stage and by study arm) 
and reasons for attrition if known. Pre-specified criterion 2: 
proportion of eligible participants who consent at least 60%. 
Pre-specified criterion 3: proportion of participants who are 
followed up at 6 months post randomisation at least 70%.
[3] Acceptability of research procedures and outcome meas-
ures: evaluation based on participant interviews exploring 
their experience of study procedures; drop-out rates; rates of 
missing data. Pre-specified criterion 4: proportion of missing 
data (per scale for all scales other than the Depression Intensity 
Scale Circles, DISCS) less than 15% for participants with mild 
to moderate receptive aphasia, defined as scoring ≥7 on the 
receptive domains of the Frenchay Aphasia Screening Test 
(FAST). Pre-specified criterion 5: proportion of all participants, 
including those with severe receptive aphasia, able to complete 
DISCS at least 90%.
[4] Feasibility of delivering the intervention by experienced 
speech and language therapists: evaluation based on inter-
views with trial clinicians at end of the study and qualitative 
evaluation of the clinical supervisor’s records of clinical super-
vision sessions. In addition, the process of assessing fidelity 
will provide further insight into the extent to which speech 
and language therapists were able to deliver the intervention as 
intended.
Secondary endpoints 
[5] Appropriateness of outcome measures: evaluation based on 
level of variability of scores; missing data; floor or ceiling effects; 
whether scale constructs match any changes described during 
in-depth interviews; participant perspective on acceptability.
[6] Estimating sample size: based on means and standard devia-
tion of proposed primary clinical outcome measure (Warwick 
Edinburgh Mental Well-Being Scale,37) and retention rates.
[7] Assessing treatment fidelity processes: evaluation based on 
acceptability of fidelity checking processes to trial clinicians 
and participants; utility and reliability of the fidelity check-list; 
and extent to which treatment is delivered as intended 
(i.e. compliant with the therapy manual).
[8] Feasibility of documenting usual care and resource use: 
evaluation based on the acceptability and completeness of data 
generated by the adapted version of the Client Service Receipt 
Inventory (CSRI)38.
Patient reported outcome measures. Primary and secondary 
outcomes: The primary clinical outcome in a future trial is likely 
to be psychological well-being, measured using the Warwick 
Edinburgh Mental Well-being Scale (WEMWBS)37. Potential 
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secondary clinical outcomes will likely measure mood (General 
Health Questionnaire-12 item version39, and Depression Intensity 
Scale Circles40); and communicative participation (Commu-
nicative Participation Item Bank41). These measures will be 
tested in the current trial, and will be completed in face-to-face 
interview format at baseline, and at three and six months post 
randomisation, with additional visit nine months post randomi-
sation for the wait-list group. The presentation of measures will 
be modified to make them accessible to people with aphasia 
in line with best practice42: participants will be able to read 
Figure 2. SOFIA CONSORT flow diagram.
Page 9 of 18
AMRC Open Research 2019, 1:11 Last updated: 28 AUG 2019
items as well as hear them; few items will be presented per 
page; a large font will be used; and participants will be able to 
point to their preferred response option. Practice items will be 
introduced for each scale to ensure participants understand 
the response formats. The content of the measures will not 
be changed to avoid affecting their psychometric properties. 
The visits will be conducted by research assistants who are 
qualified speech and language therapists able to facilitate responses 
of people with aphasia as appropriate. The measures chosen 
have all been successfully used with people with aphasia in 
previous research projects25,44. The research assistants will receive 
initial training in completing the outcome measures as well as 
ongoing support to ensure consistency of approach.
Profiling and co-variate measures: the Frenchay Aphasia Screen-
ing Test31 will be conducted at baseline. Further, a measure of 
therapeutic alliance, the Session Rating Scale36, will be completed 
during the in-depth interview by an unblinded researcher.
Economic evaluation measures: participants will complete 
the EQ-5D-5L43 measure at baseline, and all subsequent 
post-randomisation assessment points. An adapted version of the 
Client Service Receipt Inventory (CSRI)38 will be collected by 
an unblinded research assistant at six months post randomisa-
tion, capturing data for the previous 3 months. Modifications have 
been made to the CSRI so that it is more relevant and accessible 
to people with aphasia (Extended data29).
Sample size
We will recruit 32 participants, 16 participants allocated to 
each arm. This is line with recommendations which suggest a 
sample size of between 24 and 50 for a feasibility study45–47. 
This is considered sufficient to estimate the parameters of a 
larger trial, such as recruitment rates, consent rates, completion 
rates and standard deviation of outcome measures, with 
acceptable precision. We anticipate at least 24 participants 
will be followed up at 6 months, the likely endpoint in a 
future definitive trial. Effect sizes gained from the 6 month 
data point will be used to inform the sample size calculations 
of the future definitive trial. A recent aphasia therapy feasibil-
ity trial with a similar sample size (n=34) generated sufficiently 
useful information to enable progression to the definitive Big 
Cactus trial33,48. In addition to collecting quantitative data, we 
are also inviting all participants to take part in in-depth inter-
views. Assuming at least 24 participants complete post therapy 
interviews, we anticipate this sample will enable us to capture 
a diverse range of perspectives into how the intervention has 
been experienced by this client group49.
Data management and monitoring
The trial databases will be hosted at City, University of London, 
on a password-protected secure network drive accessed only 
by named personnel. The datasets will be anonymised with par-
ticipants being identified by their unique Participant Identification 
Number. Data will be entered by authorised staff (SN and 
research assistants) with a full audit trail. Internal audit-
ing of the data collected will occur throughout the trial. Data 
will be monitored for completeness and accuracy, with range 
and logic checks conducted and a random selection of at least 
20% of the data double checked. The chief investigator (SN) 
will meet with four senior academic supervisors every month 
throughout the project. This Academic Supervisory Group 
will monitor the progress of the trial including recruitment and 
adherence to protocol, as well as participant safety. In addi-
tion, a Trial Steering Committee (TSC) will meet three times 
over the course of the trial to monitor study progress, adverse 
Table 2. Outcome measures used in SOFIA study.
Outcome measure Construct Modifications made for SOFIA Trial
Clinical Outcomes
Warwick Edinburgh Mental Wellbeing Scale 
(WEMWBS)37
Mental wellbeing Presentation, not content, adjusted to be more accessible to 
people with aphasia.
General Health Questionnaire – 12 item version (GHQ)39 Psychological 
Distress
Presentation, not content, adjusted to be more accessible to 
people with aphasia.
Depression Intensity Scale Circles (DISCS)40 Depression No modifications
Communicative Participation Item Bank (CPIB)41 Communicative 
Participation
Presentation, not content, adjusted to be more accessible to 
people with aphasia.
Profiling and co-variate
Frenchay Aphasia Screening Test (FAST)31 Language No modifications
Session Rating Scale (SRS)36 Therapeutic alliance Author of SRS has created two versions. Linguistically 
simpler version used.
Economic Evaluation
European Quality of Life, 5 Dimension, 5 Levels (EQ-
5D-5L)43
Health-related 
quality of life
Presentation, not content, adjusted to be more accessible to 
people with aphasia.
Adapted Client Service Receipt Inventory (CSRI)38 Service and 
resource use
Modifications made to both presentation and content so as 
to be more relevant and accessible to people with aphasia.
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events, and advise on continuing or stopping the trial. As this 
is a small low-risk trial, the TSC will also take on the role of a 
Data Monitoring Committee. There are no planned interim anal-
yses. The decision to stop the trial early on grounds of safety 
or futility will be made by the TSC, for example, if we fail to 
recruit, or have very low adherence rates. Any significant amend-
ments to the protocol will be communicated to all relevant 
authorities including the TSC, the sponsor, the funder, the Health 
Research Authority, and the relevant trial registry.
Analyses
Quantitative analysis. As a feasibility study the main end-
points relate to the feasibility objectives listed above. Descriptive 
statistics will be calculated for feasibility outcomes, along with 
95% confidence intervals as appropriate.
In terms of clinical outcomes, descriptive statistics will be 
presented for the primary clinical outcome measure of psycho-
logical well-being (WEMWBS) and three secondary outcomes 
(mood, GHQ-12, DISCS; and participation, CPIB). We will 
present the GHQ-12 data both as an overall score (range: 0 to 12); 
and also as categorical data (participants scoring <3 classified 
as having no or low distress). These measures will be sum-
marised using summary statistics measuring central tendency 
and dispersion, for the entire trial population and by trial arm, 
at each time point, including nine months post randomisation 
for the wait-list group. Means and confidence intervals will be 
plotted over time. Summary statistics will also be presented for 
the co-variate outcomes measuring aphasia severity (FAST) 
and therapeutic alliance (SRS).
Since the intervention is therapist led, we will estimate the intra 
cluster correlation coefficient (ICC) for participants treated 
by the same therapist for outcomes six months post randomi-
sation using a random effects model. In addition, we will 
report on appropriate effect sizes, along with associated 95% 
confidence intervals, for the clinical outcomes. We will use a 
random effects model which adjusts for therapist effect and also 
includes the baseline outcome as a covariate. We will use this data 
to estimate the sample size for the definitive trial.
One of the aims of the trial is to explore the acceptability of 
the intervention and measures for people with severe aphasia 
(for this trial classified as scoring as <7 on either expressive 
or receptive domains of the FAST). As secondary analysis, we 
will additionally present the data for people with severe aphasia 
separately from people with mild to moderate aphasia for all 
outcome measures: any noteworthy differences between these 
two groups will be reported descriptively as group size is small.
We will also conduct missing values analysis at the item level, 
scale level, and per administration as well as report the number 
of participants who have complete data for each time point, 
by treatment group and overall. The aim will be to build a 
picture of the characteristics of participants with missing 
data. The nature of the missing data will inform our evalua-
tion of the acceptability of the different measures for this client 
group.
Qualitative analysis. Qualitative data will be reported accord-
ing to the Standards for Reporting Qualitative Research Guide-
lines (SRQR)50. The primary source of data will be the in-depth 
interviews with participants and therapists, although we will 
also refer to therapy and supervision records. All interviews 
will be recorded with consent and transcribed verbatim. Data 
will be analysed using Framework Analysis51 where raw data 
is tagged using a thematic index and is then synthesised into 
thematic matrices enabling between and within case analyses.
Health economics analysis. We will present the relevant costs 
and health outcomes for both the intervention group and the 
control group. For the costs, we will use data collected from the 
adapted CSRI at 6 months post randomisation: it will capture 
data from the previous 3 months. Costs will be derived from 
identifying resources used in terms of health and social care 
service use, intervention costs, as well as informal care costs 
and costs to the individual. Unit costs of resources used will be 
derived from routine sources locally where possible and from 
national sources such as the NHS reference costs. We will use 
the relevant annual costing manual corresponding to the date 
when the resource use data was collected. We will also refer 
to the unit costs for health and social care compiled by the 
Personal Social Services Research Unit52.
Health gains will be obtained from WEMWBS and the EQ-
5D-5L. These measures will inform two types of exploratory 
economic evaluation analysis, to ascertain the potential cost per 
unit of change in quality of life using each of the WEMWBS 
and EQ-5D-5L measures. Additionally, we will provide an esti-
mate of the relative cost-effectiveness of care received in the 
intervention group compared to the wait-list control group: 
this is intended to inform the design of the economic analysis 
in a larger trial and will be exploratory in nature. We will 
examine the completeness of the data. We will also explore the 
acceptability and potential burden of the economic measures 
to people with aphasia and their family members, for example, 
in terms of time taken to complete.
Service user involvement
When developing the funding proposal we held a workshop 
with people who had post-stroke aphasia, both mild and severe, 
as well as a carer. This workshop influenced the choice of 
control group, the decision to target people at least six months 
post stroke, and to include people who had severe aphasia in the 
trial. In setting up and monitoring the current trial the SOFIA 
Aphasia Advisory Group is meeting eight times. The group is 
made up of four people with aphasia and one family member, 
including two people who have experience of receiving the inter-
vention. The group has already provided advice on: the design 
of project information including the participant information 
sheet; recruitment process; presentation of outcome measures; 
topic guide for the in-depth interviews; ideas to improve the acces-
sibility of the therapy approach; and ways to enhance the partici-
pant experience. They have additionally contributed to therapist 
training. In future meetings they will advise on issues in the trial 
as they arise; discuss interpreting findings and dissemination; 
and consider ways to build a community around the project.
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Adverse events, ancillary care and post-trial care
This study is exploring a non-physical non-invasive interven-
tion. As such, adverse events related to participating in the study 
are considered unlikely. Research assistants and trial clinicians 
will report all adverse events, both related and unrelated to the 
study, to the chief investigator. For the purposes of this trial, a 
participant scoring >3 on the GHQ-12, indicative of moderate 
psychological distress, is considered an adverse event. In this 
case, the research assistant will follow a set protocol. They will 
seek permission for the chief investigator to share the results 
with their primary care physician (General Practitioner, GP). 
They will also advise the participant to visit their GP and facili-
tate this visit as required. The participant will be given the 
choice as to whether to remain in the project. If a research assist-
ant or trial clinician has serious concerns about a participant’s 
mental or physical well-being a decision will be made with the 
participant and other relevant authorities about what is in their 
best interests, for example, escalation of psychological care 
and potentially withdrawal from the study.
In terms of ancillary care, all research assistants and trial 
clinicians are also qualified speech and language therapists who 
will receive additional training for the trial from the chief inves-
tigator, as well as ongoing support. They will be able to listen to 
participant concerns and will be trained to respond appropriately 
to participant distress. They will also receive training on the 
core values of the project which prioritise a positive participant 
experience during all research visits e.g. participants should feel 
valued and respected when collecting outcome data; research 
assistants are encouraged to take an interest in participants as 
people. In addition, information about local support sources 
will be offered if participants express feelings of loneliness 
or low mood. All participants have met the chief investigator 
during the initial information giving visit. The SOFIA Aphasia 
Advisory Group advised that the potential participant should be 
listened to holistically during this visit and that the process 
should feel two way. Participants and their families are given 
the chief investigator’s direct work phone line and email address 
and are encouraged to contact the chief investigator if they have 
concerns. Further, it is the chief investigator who communicates 
their group allocation and is in contact with them throughout 
the trial to confirm or arrange follow up visits, providing 
continuity. Where possible, we also organise that it is the 
same research assistant who conducts the first three assessment 
visits. Participants will not receive any financial incentives to take 
part in the trial.
In terms of post-trial support, the final visit for all participants 
is an in-depth interview with a researcher unblinded to treat-
ment allocation and aware of how they have progressed through 
the trial (e.g. with access to their therapy records and outcome 
data). This researcher is well placed to talk through different 
options going forward (e.g. discuss voluntary organisations 
that offer support and other opportunities within the university), 
as well as thank them for their contribution and let them know 
what to expect next.
Dissemination policy
The results of the study will be reported and disseminated 
at academic and clinical conferences and in peer-reviewed 
scientific journals, as well as to our funder and the two NHS 
sites. Our SOFIA Aphasia Advisory Group will advise on how 
best to disseminate the results to the public and stroke com-
munity, for example, writing in the newsletters of stroke and 
aphasia voluntary organisations, attending stroke events or 
via social media. We will also work with the SOFIA Aphasia 
Advisory Group to create an aphasia-accessible results leaflet to 
explain the results to participants and others involved in the trial, 
as well as holding a dissemination event.
Study status
The recruitment was scheduled to take 13 months, from 31st 
October 2017 until 30th November 2018. Recruitment began 
two weeks earlier than planned on 17th October 2017, and 
was completed on 5th November 2018. Data collection has not 
yet been completed and the study is ongoing.
Discussion
This study will evaluate the feasibility of conducting a defini-
tive randomised controlled trial evaluating clinical and cost 
effectiveness of Solution Focused Brief Therapy for people living 
with chronic post-stroke aphasia. The aim of the therapy is 
to enhance the psychological well-being of people with 
aphasia.
The current study may provide valuable information on ways to 
adapt a psychological talk-based therapy so that it is accessible 
to people with a communication difficulty. We decided to 
include people with severe aphasia. There is evidence that peo-
ple with severe aphasia have significantly lower health-related 
quality of life than people with mild to moderate aphasia53; have 
three-fold worse activity limitations in communication than 
those with moderate aphasia54; and are at high risk of social 
exclusion55. Preliminary evidence from a pilot study linked to 
the current trial suggested that it was possible to modify the 
approach to make it communicatively accessible to people 
with severe aphasia, and that they found the therapy approach 
acceptable56. The SOFIA study will provide further informa-
tion on whether there are particular presentations of aphasia 
which make the approach less acceptable. A potential chal-
lenge of including people with more severe aphasia is exploring 
how best to capture any change. We took the decision to 
collect data directly from participants rather than rely on proxy 
responses, as there are is some evidence that that proxy responses 
are not commensurable with self-report, particularly for less 
observable, more subjective constructs. Proxies tend to score 
people with aphasia as more severely affected than the people 
with aphasia scores themselves57,58. We have carefully selected 
measures which have been used successfully with people with 
aphasia in previous studies, and will monitor closely whether 
people with more severe aphasia are able to self-report on all 
the chosen measures in order to inform our choice of measures 
in the definitive trial.
In conclusion, this study will assist in building the evidence 
base for potential effective interventions for a client group 
excluded from most stroke research exploring psychological 
interventions. The study may also provide useful information 
on the viability of speech and language therapists delivering a 
psychological intervention, including their perspective on support 
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and training needs. Finally, the intervention and the therapist 
training are both relatively brief suggesting that the approach 
has the potential to be integrated into routine clinical practice.
This paper reports on protocol version 2 (date: 24th August 2017).
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© 2019 Baker C. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
   Caroline Baker
Centre of Research Excellence in Aphasia Rehabilitation, School of Allied Health, La Trobe University,
Bundoora, Vic, Australia
Thank you for the opportunity to review this study protocol paper. 
This study protocol describes a trial to explore the acceptability of Solution Focused Brief Therapy (SFBT)
for people with aphasia after stroke. It provides a highly valuable contribution to the field of aphasia
rehabilitation and research, in terms of: 1) exploring a potential intervention to directly target psychosocial
outcomes; 2) tailoring the intervention to the individual’s communication needs and supports; and 3)
including people with aphasia of varying severities (mild through to severe) in stroke research, both as
participants and as advisors to the study trial. 
Review questions:
Is the rationale for, and objectives of, the study clearly described?
Yes, the introduction provides background information about the lack of psychological therapies for
people with aphasia and the potential for SFBT to enhance psychosocial outcomes.  Importantly, the
SOFIA trial will extend on a preliminary study by Northcott, Burns, Simpson et al. (2015)  that showed
positive trends in mood and communication participation and confidence.
The aim of the study is clearly stated. The primary and secondary objectives are clearly described.
  For clarity, please add the clinical population for whom SFBT was effective when citingMinor point:
reference 22 (neurotypical population?). “The strongest evidence for the effectiveness of SFBT is in
treating depression.” 
Is the study design appropriate for the research question?
Yes, the study design (a single-blind, randomised, wait-list controlled feasibility trial) aligns with the
research aim and objectives described.
Are sufficient details of the methods provided to allow replication by others?
Yes, sufficient details have been provided and the authors have used evidence-based statements and
guidelines [e.g.,Consolidated Standards of Reporting Trials (CONSORT), 2010] to inform the study
design and protocol report. The primary and secondary clinical outcome measures for participants with
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guidelines [e.g.,Consolidated Standards of Reporting Trials (CONSORT), 2010] to inform the study
design and protocol report. The primary and secondary clinical outcome measures for participants with
aphasia are clearly described and appropriate. To the best of my knowledge, the concealed
randomisation process by an independent service is appropriate following baseline assessments. The
intervention is described in Table 1 using the TIDieR checklist. The authors have offered contact details of
the corresponding author (Sarah Northcott) for further details about the therapy approach. The use of both
quantitative and qualitative analyses is appropriate for informing the feasibility of SFBT for people with
aphasia.
 Recruitment is stated as completed on 5  November 2019 – should this read as: will beMinor points:
completed or expected to be completed by 5  November 2019?
While I, (Caroline Baker) have knowledge and skills to review most aspects of the content, I have limited
experience in statistical analysis. The quantitative analyses are described and appear appropriate, to the
best of my knowledge. However, the editors may consider a review of the quantitative and health
economic analyses by someone with expertise in this area.         
Are the datasets clearly presented in a useable and accessible format?
There are no data sets associated with this article.
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156-67   |   PubMed Abstract Publisher Full Text
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: I am a speech pathologist and my primary area of research is translating
psychological care to aphasia rehabilitation. Due to limited experience in statistical analysis, the editors
may consider review of quantitative and health economic analysis by someone with expertise in this area.
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
Author Response 10 Jul 2019
, City, University of London, London, UKSarah Northcott
We are very grateful to you for taking the time to read and consider this article, and for your
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We are very grateful to you for taking the time to read and consider this article, and for your
thoughtful and encouraging observations. Thank you for drawing our attention to the mistake in the
recruitment window. In line with your suggestion, we have also clarified that Reference 22 is
referring to neurotypical adults. Once again, thank you for taking the time to reflect on this article. 
 No competing interests were disclosed.Competing Interests:
 10 June 2019Reviewer Report
https://doi.org/10.21956/amrcopenres.13939.r26426
© 2019 Carter M. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
 Mary Carter
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
This feasibility study concerns an important area of research and aims to find a way of helping a group of
people who report feelings of isolation and poor psycho-social health. I have previous experience of
working with people with aphasia , so I was pleased to be asked to review this paper.
 
The protocol is very thorough and the authors have included all the details pertinent to a protocol for a
randomised controlled trial. The style of writing is clear and cogent. The tables, figures, signposts to
supplementary materials and references add to the coherence and clarity of the overall paper.  The
inclusion of a proof-of-concept study adds weight to the design and detail of the feasibility study. 
The involvement of service users with direct experience of aphasia throughout the study development and
implementation provides a high degree of credibility to the research.  The contributions of service users to
future reports and articles will be particularly valuable.
 
I definitely recommend indexing of this protocol.
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Thank you for this encouraging and thoughtful review. We agree that involving people with aphasia
in developing and implementing this research has strengthened the study: we will follow your
suggestion of including our Aphasia Advisory Group when preparing future reports, articles and
other forms of dissemination. Thank you for taking the time to read and reflect on this protocol
article. 
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